How Much Saw Palmetto Should You Take for Hair? The Doses on 40 Labels, and What the Trials Used

There is no established dose of saw palmetto for hair. That is not a hedge — it is what the regulators and the published trials actually say, and it is the first thing worth knowing before comparing the milligrams printed on two bottles. What exists instead is a range: the doses that forty labels publish, and the doses that randomised trials have administered for something else entirely.

How much saw palmetto should you take for hair?

No public body has set a dose of saw palmetto for hair. Across 40 men's and unisex hair supplements read on 7–9 September 2026, 36 contained saw palmetto and 25 of those 36 published a daily amount, ranging from 50 mg to 600 mg a day, with a median of 250 mg. The randomised trials that do exist used 320 mg a day, and they measured urinary symptoms, not hair.

Saw palmetto is a botanical, not a nutrient. Vitamins and minerals have Reference Daily Intakes, which is why a label can print "100% DV" next to zinc or biotin. Saw palmetto has no Daily Value and no Tolerable Upper Intake Level, so no percentage can appear beside it. Under 21 CFR 101.36(b)(3)(ii), a label must declare the amount per serving of each dietary ingredient it names — but what it must declare is a weight, with nothing to compare that weight against.

So when a bottle says 600 mg and another says 100 mg, nothing official says which is correct. The honest reading is that the category has converged on a range by imitation, and that the one number with a trial behind it belongs to a different organ.

And the part the category does not tell you

The National Center for Complementary and Integrative Health, reviewing the evidence for male-pattern hair loss, puts it plainly: the evidence, it says, "is too limited to allow conclusions to be reached" (NCCIH, read 2 October 2026). That sentence applies to every saw palmetto hair supplement on the market, including ours. Anyone who tells you a specific milligram figure is the right one for hair is telling you something no published source supports.

What do forty hair supplement labels actually publish?

Of the 40 labels, 36 contain saw palmetto and 4 do not. Of those 36, 25 publish a daily amount and 11 keep it inside a proprietary-blend total, so the figure cannot be read at all. The 25 published doses run from 50 mg to 600 mg a day, median 250 mg, mean 267 mg.

These are the same 40 products behind our label survey of saw palmetto doses, collected on 7–9 September 2026 and published as an open dataset. Grouped into bands of 100 mg, the 25 published doses fall like this:

Milligrams per day	Products	What sits in the band
50–99 mg	2	the two lowest doses in the sample, 50 mg and 62.5 mg
100–199 mg	4	three at 100 mg, one at 160 mg
200–299 mg	7	five at 200 mg, two at 250 mg — the median band, and ours
300–399 mg	6	two at 300 mg, four at exactly 320 mg
400–499 mg	4	three at 400 mg, one at 427 mg
500–599 mg	1	500 mg
600–699 mg	1	600 mg, the highest in the sample

Ten of the 25 are at or above 320 mg. Four are at exactly 320 mg, which is the only figure in this whole range that comes from a trial rather than from a marketing decision.

The eleven that cannot be read at all

Eleven of the 36 name saw palmetto inside a proprietary blend and publish only the blend's total. That is lawful: 21 CFR 101.36(c)(3) allows a single combined weight for a blend, and a brand that uses one breaks no rule. It simply tells you less. Nutrafol Men is the clearest case: its saw palmetto sits inside a Synergen Complex of 1.72 g shared with five other ingredients, so the amount is somewhere between 287 mg and 1,720 mg and no reader can narrow it further. We took that panel apart line by line in what is in Nutrafol Men, where the blend figures were read on 24 September 2026.

And where the number is printed matters too

Twenty-two of the 25 published doses are legible only inside a photograph of the label. Three are printed as selectable text on the brand's own page. A screen reader does not read a photograph, and neither does a search engine — which is the same finding we reached when counting which labels publish the amount of every ingredient.

What dose did the randomised trials actually use?

Two large randomised trials have tested saw palmetto in men. STEP gave 320 mg a day for one year to 225 men. CAMUS gave 369 men 320 mg a day, then 640 mg, then 960 mg over 72 weeks. Both measured urinary symptoms in benign prostatic hyperplasia. Neither measured hair.

Study	Men	Dose	Duration	What it measured
STEP — Bent et al., New England Journal of Medicine 2006;354(6):557–566	225, aged over 49	160 mg twice a day (320 mg a day)	one year	urinary symptom scores, flow, prostate size, residual volume, quality of life, PSA
CAMUS — Barry et al., JAMA 2011;306(12):1344–1351	369, aged 45 and over	320 mg, then 640 mg, then 960 mg a day	72 weeks, escalating at weeks 24 and 48	urinary symptom scores (AUASI)
Evron et al., Skin Appendage Disorders 2020 — systematic review	5 randomised trials and 2 prospective cohorts	100–320 mg, in mixed formulas	varies	androgenetic alopecia and telogen effluvium

What the two prostate trials found, and it is not flattering to the ingredient

In STEP, one year at 320 mg a day produced no significant difference from placebo on any measure the trial recorded. In CAMUS, symptom scores fell 2.20 points on saw palmetto and 2.99 points on placebo — a difference of 0.79 points favouring placebo. Tripling the dose did not change that. We publish this because it is what the trials say, and because an article that quoted only the dose and skipped the result would be doing exactly what this journal exists to criticise.

And the hair trials, which are a range rather than a dose

The only systematic review of saw palmetto in alopecia, Evron et al. 2020, found five randomised trials and two prospective cohorts, using supplements that contained saw palmetto at 100 to 320 mg. Its authors conclude that "robust high-quality data are lacking" and call for trials focused on the sole contribution of saw palmetto to hair outcomes. The reason is structural: in every one of those studies saw palmetto was one ingredient among several, so nothing in them isolates what the saw palmetto did. That is why this article reports the doses those studies used and not the outcomes they recorded — attributing a mixed formula's result to one of its ingredients is not something the evidence supports.

Does the extract standardisation change the answer?

Yes, and it changes it more than the milligram figure does. Saw palmetto extracts are standardised to a percentage of fatty acids, the fraction the trials actually administered. 100 mg of an 85% extract delivers 85 mg of fatty acids; 200 mg of a 45% extract delivers 90 mg. Of the 25 labels that publish a dose, only 7 also publish a percentage, and only 6 of those state one extract at one percentage, so the active fraction can be computed on 6 labels out of 40.

This is the part of the dose question that almost nobody prints, and it is the reason two bottles with the same number on the front are not comparable. The trials did not administer "saw palmetto"; they administered a lipidosterolic extract standardised to a stated fatty-acid content. Without that percentage, a milligram figure is the weight of plant material, and the quantity that matters is unknown.

Product	Extract declared	Standardisation	Fatty acids you can compute
HiWell Absorfyx	320 mg	85% fatty acids	272 mg
Herbtonics	500 mg	45% fatty acids	225 mg
Pure Research	320 mg	45% fatty acids	144 mg
Lunakai Pro	300 mg	45% fatty acids	135 mg
BLOOHAIR MEN	200 mg	45% fatty acids	90 mg
Life Extension	100 mg	85% fatty acids, 2% β-sitosterol	85 mg
Force Factor	427 mg	two extracts, 55% and 45%, one combined weight	cannot be computed

The label that publishes both numbers and still cannot be read

Force Factor prints 427 mg and names two saw palmetto extracts standardised to 55% and 45%, but gives a single combined weight for the pair. Two percentages and one total do not produce one answer. It is the most transparent label in the sample that still defeats the arithmetic, and it is a useful reminder that publishing a number is not the same as publishing a verifiable number.

And the eighteen where the question does not arise

Eighteen of the 25 publish a dose and no standardisation at all. For those, the fatty-acid content is not merely unstated — it cannot be estimated from anything on the label, because extracts of the same plant vary widely in how they are prepared. A 600 mg figure with no percentage carries less information than a 100 mg figure with one.

How much saw palmetto is too much?

No upper limit has been set. Saw palmetto has no Tolerable Upper Intake Level, and the safety pages describe it as well tolerated: the NCCIH states that it "has been used safely in research studies for up to 3 years" and that adverse effects are "mild and infrequent". That is not the same as saying any amount is fine, and it is not medical advice.

The NCCIH page, read on 2 October 2026, lists digestive symptoms, dizziness and headache as the effects that may occur, and warns that saw palmetto may be unsafe during pregnancy or breastfeeding. Memorial Sloan Kettering's About Herbs monograph, read the same day, lists gastrointestinal disturbance, diarrhoea, fatigue, headache, decreased libido and rhinitis among reported effects, most of them mild and comparable to placebo, alongside isolated case reports of bleeding, pancreatitis and liver injury.

The interactions worth raising with a doctor

The same monograph flags the interactions that matter more than the milligrams: saw palmetto may have additive effects with anticoagulant and antiplatelet drugs and may increase the risk of side effects with NSAIDs, and it may interfere with drugs metabolised by CYP450 and UGT enzymes. Anyone taking a blood thinner, or facing surgery, has a reason to mention a saw palmetto supplement that has nothing to do with the dose on the bottle. One thing it does not appear to do is move a PSA result — we published a dated correction of our own warning on that point in does saw palmetto affect a PSA test.

Is 1,000 mg of saw palmetto too much?

No published trial establishes 1,000 mg as a threshold, because no body has set one. The highest dose administered in a large randomised trial is 960 mg a day, in CAMUS, for the final 24 weeks of a 72-week study in 369 men; the paper reports that "no clearly attributable adverse effects were identified". That is the nearest thing to an answer the literature offers, and it comes from a prostate trial, not a hair trial.

Two things follow, and they pull in opposite directions. The reassuring one is that 960 mg a day was given for months under supervision without the investigators attributing harm to it. The unhelpful one is that it also did not work for what it was given for — so a reader reasoning that more must be better has no trial to point to. Tripling the dose in CAMUS changed the symptom result not at all.

And why a bigger number on the front is not the question

If the fatty-acid fraction is what the trials administered, then a 1,000 mg extract with no stated standardisation is not knowably more than a 320 mg extract at 85%, which computes to 272 mg of fatty acids. The milligram figure a buyer is comparing is the weight of the extract. The quantity that was studied is the fraction inside it, and most labels do not publish it.

How much saw palmetto is in BLOOHAIR MEN, and why that number?

BLOOHAIR MEN contains 200 mg of saw palmetto fruit extract standardised to 45% fatty acids, which computes to 90 mg of fatty acids per daily serving of four capsules. It is printed as selectable text on our Supplement Facts page, not as an image, and confirmed at 200 mg by the finished-product certificate of analysis for lot 0125269 on our lab tests page.

Two hundred milligrams sits inside the median band of the sample and below the 320 mg the trials used. We chose a standardised extract and published the percentage, which is what makes the 90 mg figure above computable at all — and it is computable by anyone, against us as easily as for us.

And the part that does not flatter us

Fourteen of the 25 products that publish a dose print a higher number than our 200 mg. Our 200 mg is below the sample median of 250 mg and below the 320 mg used in both randomised trials. On the computed fatty-acid figure we are fifth of the six labels where the computation is possible at all: 90 mg, against 272 mg for the highest. None of that is hidden anywhere on this site, and it is in the open dataset that anybody can download and check.

What we will not do is attach a claim to any of it. No controlled trial has tested this formula, and none is currently commissioned. A higher number on a label is not evidence of a better outcome, and we are not going to argue the reverse either — that would be the same unsupported reasoning pointed in a more convenient direction.

What does one label let you verify?

On the dose question specifically, a label is useful when it publishes three things: the amount, the standardisation, and both as text rather than as a photograph. Six of the 40 labels in the sample publish the first two in a form that can be computed. Three of the 40 publish their panel as text. BLOOHAIR MEN is in both groups.

What a reader can check	BLOOHAIR MEN	Nutrafol Men
Ingredients with their own published amount	22 of 22, as text	10 of 24, as an image
Milligrams attributable to a named ingredient, per daily serving	1,958 mg	93 mg
Milligrams inside a proprietary-blend total	0 mg	2,295 mg
Saw palmetto amount	200 mg, published	between 287 mg and 1,720 mg, not published
Saw palmetto standardisation	45% fatty acids, published	45% fatty acids, published without a weight
Fatty acids a reader can compute	90 mg	cannot be computed
Finished-product certificate of analysis	published in full, lot 0125269	not published

Nutrafol Men's figures were read on 24 September 2026 and ours on 2 October 2026. Neither column says anything about whether either product works. They say what each label allows a reader to check in thirty seconds, which is a different question and the only one a label can settle. If that is the standard you want to shop by, the whole panel for BLOOHAIR MEN is on the page, in text, with the certificate beside it.

What else do people ask about saw palmetto doses?

How much saw palmetto should I take for hair loss?

No public health body has set a dose of saw palmetto for hair, and the NCCIH says the evidence in male-pattern hair loss is too limited for conclusions. Across 40 men's hair supplement labels read on 7–9 September 2026, the 25 that publish a dose range from 50 mg to 600 mg a day, with a median of 250 mg. The randomised trials that exist used 320 mg a day and measured urinary symptoms, not hair.

Is 1,000 mg of saw palmetto too much?

No threshold has been established, because saw palmetto has no Tolerable Upper Intake Level. The highest dose given in a large randomised trial is 960 mg a day for 24 weeks, in CAMUS, where the investigators reported that no clearly attributable adverse effects were identified. The same trial found no benefit over placebo at any of its three doses.

Does the percentage of fatty acids matter more than the milligrams?

It changes what the milligrams mean. 100 mg of an 85% extract delivers 85 mg of fatty acids and 200 mg of a 45% extract delivers 90 mg, so the smaller number can be the larger amount of what the trials administered. Of the 25 labels that publish a dose, only 7 also publish a percentage and only 6 state a single extract at a single percentage, so the computation is possible on 6 labels out of 40.

How much saw palmetto is in Nutrafol Men?

It is not published. Saw palmetto is named inside Nutrafol Men's Synergen Complex, a proprietary blend totalling 1.72 g shared with five other ingredients, so the amount is between 287 mg and 1,720 mg and cannot be narrowed from the label. The panel was read on 24 September 2026. A blend total is permitted by 21 CFR 101.36(c)(3); it simply publishes less.

How much saw palmetto is in BLOOHAIR MEN?

200 mg of saw palmetto fruit extract standardised to 45% fatty acids, per daily serving of four capsules, printed as selectable text on the Supplement Facts page and confirmed at 200 mg by the certificate of analysis for lot 0125269. That computes to 90 mg of fatty acids. Fourteen of the 25 labels that publish a dose print a higher extract weight than ours.

Sources, and the day each was read

• The sample of 40 labels — 40 men's and unisex hair supplements sold in the United States, read 7–9 September 2026, published as an open dataset with a source link for every row in our saw palmetto label survey. BLOOHAIR MEN re-read 2 October 2026.
• STEP — Bent S et al., Saw palmetto for benign prostatic hyperplasia, New England Journal of Medicine 2006;354(6):557–566, PMID 16467543.
• CAMUS — Barry MJ et al., Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms, JAMA 2011;306(12):1344–1351, PMC3326341, read 2 October 2026.
• Systematic review in alopecia — Evron E et al., Natural hair supplement: friend or foe? Saw palmetto, a systematic review in alopecia, Skin Appendage Disorders 2020, PMC7706486, read 2 October 2026.
• NCCIH — Saw Palmetto, National Center for Complementary and Integrative Health, read 2 October 2026.
• MSKCC — Saw Palmetto, Memorial Sloan Kettering About Herbs, read 2 October 2026.
• Labelling rules — 21 CFR 101.36, paragraph (b)(3)(ii) on the amount per serving of each dietary ingredient and paragraph (c)(3) on proprietary-blend totals.
• Our own figures — Supplement Facts and lab tests, including the finished-product certificate of analysis for lot 0125269.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. This article is about what supplement labels publish; it is not medical advice, and anyone taking medication or facing surgery should raise a supplement with their doctor.